PF07104091

Item number	Size	Delivery time	Price
TGM-T9712-1mg	1 mg	7 - 10 business days*	364.00€
TGM-T9712-2mg	2 mg	7 - 10 business days*	534.00€
TGM-T9712-5mg	5 mg	7 - 10 business days*	850.00€
TGM-T9712-1mL	1 ml	7 - 10 business days*	944.00€
TGM-T9712-10mg	10 mg	7 - 10 business days*	1,245.00€
TGM-T9712-25mg	25 mg	7 - 10 business days*	1,854.00€
TGM-T9712-50mg	50 mg	7 - 10 business days*	2,503.00€
TGM-T9712-100mg	100 mg	7 - 10 business days*	3,367.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: PF07104091 inhibits CDK2, which may lead to cell cycle arrest, induce apoptosis and... more

Close menu

Product information "PF07104091"

Description: PF07104091 inhibits CDK2, which may lead to cell cycle arrest, induce apoptosis and inhibit tumor cell proliferation. Target: CDK. Smiles: N(C(=O)C1=CC(COC)=NN1C)C2=CC(=NN2)[C@@H]3C[C@H](OC(NC(C)C)=O)CC3. References: Chen Y, Cai Q, Pan C, Liu W, Li L, Liu J, Gao M, Li X, Wang L, Rao Y, Yang H, Cheng G. CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses. Cancer Immunol Res. 2022 Apr 1,10(4):525-539. doi: 10.1158/2326-6066.CIR-21-0806. PMID: 35181784.

Keywords:	PF-07104091
Supplier:	TargetMol
Supplier-Nr:	T9712

Properties

Application:	Targets cyclin-dependent kinase 2 [EC:2.7.11.22] (CDK2)
MW:	404.46 D
Formula:	C19H28N6O4

Database Information

CAS :	2460249-19-6\| Matching products
KEGG ID :	K02206 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "PF07104091"

Write a review